Cardiovascular Diseases Research in New Jersey
Cardiovascular Diseases Research (93.837) awarded $105 million to recipients in New Jersey in 85 grants from fiscal 2021 to 2025, 0.7% of the program's national total. Rutgers the State University of New Jersey received the most, $69.0 million.
- Awarded in New Jersey$105 million
- Awards85
- Share of the program0.7%
- Rank among states27th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 41 | $23.6 million |
| FY 2022 | 46 | $24.6 million |
| FY 2023 | 35 | $21.0 million |
| FY 2024 | 37 | $17.6 million |
| FY 2025 | 37 | $17.9 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 44 | $69.0 million |
| The Trustees of Princeton University | Colleges and universities | 6 | $15.9 million |
| Rutgers, the State University | Colleges and universities | 9 | $5.3 million |
| Rutgers, the State University | Colleges and universities | 7 | $5.0 million |
| Coriell Institute for Medical Research, Inc. | Nonprofits | 2 | $2.3 million |
| Coridea, LLC | Small businesses | 1 | $2.0 million |
| Rutgers, the State University | Colleges and universities | 2 | $1.6 million |
| The Trustees of the Stevens Institute of Technology | Colleges and universities | 2 | $1.0 million |
| Rowan University | Colleges and universities | 3 | $820,764 |
| Endolynx Inc | Small businesses | 1 | $506,500 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to New Jersey?
$105 million from fiscal 2021 to 2025, across 85 awards. New Jersey ranks 27th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $69.0 million in 44 awards. Next are The Trustees of Princeton University and Rutgers, the State University.
Can organizations in New Jersey apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies